Multidisciplinary Approach to Neurofibromatosis Type 1

 
 
Springer (Verlag)
  • erschienen am 2. Juni 2020
  • |
  • XII, 313 Seiten
 
E-Book | PDF mit Adobe-DRM | Systemvoraussetzungen
E-Book | PDF mit Wasserzeichen-DRM | Systemvoraussetzungen
978-3-319-92450-2 (ISBN)
 

This volume offers an update of the clinical signs, diagnostic criteria (including molecular diagnosis) and targeted therapies for a particular type of genodermatosis, providing a handy and unique tool for early diagnosis. In recent years, our understanding of genodermatosis and neurocutaneous syndromes has increased, but although Type 1 Neurofibromatosis (NF1) is the most common neuroectodermal disorder and involves a large number of patients and medical disciplines, this syndrome remains underestimated, often misdiagnosed thus leading to inaccurate treatment. The literature on the molecular and pathogenetic aspects is ample, but current clinical approaches, classification, diagnostic criteria and treatment protocols are outdated, creating difficulties in early diagnosis and treatment. As such, a chapter is devoted renewing current diagnostic criteria; it includes clinical and molecular data, to offer a sound, updated discussion basis for a consensus conference.


NF1 is a "time-dependent" disorder, meaning that the onset of clinical signs are closely linked to patient age and the book discusses this particularly neglected aspect extensively, as well as the latest molecular diagnosis techniques, which are highly sensitive have not been included in the diagnostic criteria. It also explains the role of the RAS-MAPK pathway and genotype-phenotype correlations.

In addition it explores new concepts concerning the pathogenesis of neurofibromas and other hamarthomas and their relevance for a modern therapeutical approach with targeted molecular drugs, as well as newly discovered aspects of NF1 in all internal organs, together with their diagnostic counterparts. A chapter on mosaic neurofibromatosis is also included. There is a particular focus on differential diagnosis (i.e. other diseases with café-au-lait macules), and the recently described Legius syndrome will be presented directly by Prof Eric Legius.

All chapters are easy-to-understand, up-to-date, comprehensive and concise tools and are intended for a wide range of professionals involved with genetic disorders of the skin and neurocutaneous diseases: dermatologists, pediatricians, neurologists, oncologists and general practitioners.

1st ed. 2020
  • Englisch
  • Cham
  • |
  • Schweiz
Springer International Publishing
  • 11
  • |
  • 54 farbige Tabellen, 55 farbige Abbildungen, 11 s/w Abbildungen
  • |
  • 11 schwarz-weiße und 55 farbige Abbildungen, 54 farbige Tabellen, Bibliographie
  • 10,10 MB
978-3-319-92450-2 (9783319924502)
10.1007/978-3-319-92450-2
weitere Ausgaben werden ermittelt

Gianluca Tadini, M.D., PhD., is a pediatric dermatologist, coordinator of the Center of Inherited Cutaneous Diseases (University of Milan) at the Pediatric Dermatology Unit, Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico, Milan. His main interests are genodermatoses, neuroectodermal disorders, as well as infectious and tropical diseases.

After graduating cum laude from the Medical School of Surgery (University of Milan) he earned a post graduate title in Dermatology and Venereology and one in Tropical and Subtropical Diseases, both at the University of Milan. He was a resident at the Dept of Dermatology, and the Dept Dermatology and Sexually Transmitted Diseases as well as a laboratory training resident at the University of Milan, Institute of Dermatological Sciences. He is also contract professor and students' tutor at the Department of Dermatology, School of Medicine and Surgery and postgraduate School of Dermatology and Venereology, University of Milan. Since 1991 is the coordinator of the Center of Inherited Cutaneous Diseases at the Pediatric Dermatology Unit, Ospedale Maggiore Policlinico. Doctor Tadini has authored over 200 scientific papers, lectures and lessons as a visiting professor, and was a member of the International Committee for the Classification of Ectodermal Dysplasias and Ichtyoses. He has been a consultant at the Department of Pediatrics 1, University of Milan since 2011.


Professor Eric Legius, M.D., PhD., is the head of the Human Genetics Department of the University of Leuven as well as the clinical director of the Human Genetics department of the University Hospital of Leuven. He has been chair of the Department of Human Genetics, and part time professor at the Faculty of Medicine, KULeuven. His research is targeted towards neurofibromatosis type 1 and related conditions. The research group contributed successfully towards our understanding of the molecular etiology of a number of tumors in NF1, such as benign neurofibromas, gastrointestinal stromal tumors (GIST), and glomus tumors. The group was also involved in the molecular and cognitive characterization of NF1 microdeletion region. Other projects include NF1-related oncogenesis (molecular study of malignant peripheral nerve sheath tumors) and a clinical trial to improve cognitive aspects in children with NF1 using Simvastatin treatment (NFSIMCODA-trial together with Erasmus University Rotterdam). In 2007 his research team identified a new condition resembling neurofibromatosis type 1, now known as Legius syndrome (autosomal dominant condition caused by a heterozygous mutation in SPRED1). The group uses animal models (mouse and Drosophila) to gain insights into the importance of SPRED and the RAS-MAPK pathway for cognition. He was awarded the Sidmar prize in 2010, an annual prize for medical research on a chronic disorder, Royal Academy of Medicine, Belgium, and the First Theodore Schwann Award, in 2012, at the 15th European Neurofibromatosis Meeting.

1. Epidemiology of Neurofibromatosis Type 1 Lidia Pezzani, Donatella Milani 2. Genetics and Pathway in Neurofibromatosis Type 1Ellen Denayer, Eric Legius, Hilde Brems 3. Molecular Diagnosis for NF1Ludwine M. Messiaen 4. Diagnosis in NF1, Old and NewGianluca Tadini 5. Clinical Features of NF1 in the SkinMichela Brena, Francesca Besagni, Angela Hernandez-Martin, Gianluca Tadini 6. Ocular Manifestations in Neurofibromatosis Type 1Maura Di Nicola, Francesco Viola7. Skeletal Manifestations in NF1David H. Viskochil, David A. Stevenson8. NF1 in Other OrgansEmma Burkitt Wright, Michael Burkitt and Hilde Brems 9. Genomics of Peripheral Nerve Sheath Tumors Associated to Neurofibromatosis Type 1Eduard Serra, Bernat Gel, Juana Fernández-Rodríguez, Conxi Lázaro 10. Mechanotransduction and Nf1 Loss--Partner in Crime: New Hints for Neurofibroma GenesisFederica Chiara 11. Diagnosis and Management of Benign Nerve Sheath Tumors in NF1: Evolution from Plexiform to Atypical Neurofibroma and Novel Treatment ApproachesAndrea Gross, Eva Dombi, Brigitte C. Widemann12. Diagnosis and Management of Malignant Tumors in NF1: Evolution from Atypical Neurofibromas to Malignant Peripheral Nerve Sheath Tumors and Treatment OptionsRosalie E. Ferner 13. Neurological Complications in NFUna-Marie Sheerin, Rosalie E. Ferner14. Learning Disabilities and Behavior in Neurofibromatosis Type 1 PatientsShruti Garg, Jonathan Green15. Mosaic NF1Gianluca Tadini, Teresa Schgor, Michela Brena16. Legius Syndrome, Other Café -au-lait Diseases and Differential Diagnosis of NF1Ellen Denayer, Eric Legius, Hilde Brems17. Cancer Risk and Spectrum in Individuals with RASopathies Mwe Mwe Chao, Martin Zenker, Christian Peter Kratz18. Therapeutical Approaches for NF1Bruce R. Korf 19. Medical Follow up in Neurofibromatosis Type 1Christina Bergqvist, Pierre Wolkenstein20. Brief Notes on Pregnancy, Prenatal Diagnosis and Preimplantation Procedures in NF1Gianluca Tadini, Donatella Milani21. Proposal of New Diagnostic CriteriaGianluca Tadini, Hilde Brems, Eric Legius
DNB DDC Sachgruppen

Dateiformat: PDF
Kopierschutz: Adobe-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).

Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions (siehe E-Book Hilfe).

E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Mit Adobe-DRM wird hier ein "harter" Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Bitte beachten Sie bei der Verwendung der Lese-Software Adobe Digital Editions: wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!

Weitere Informationen finden Sie in unserer E-Book Hilfe.


Dateiformat: PDF
Kopierschutz: Wasserzeichen-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Verwenden Sie zum Lesen die kostenlose Software Adobe Reader, Adobe Digital Editions oder einen anderen PDF-Viewer Ihrer Wahl (siehe E-Book Hilfe).

Tablet/Smartphone (Android; iOS): Installieren Sie die kostenlose App Adobe Digital Editions oder eine andere Lese-App für E-Books (siehe E-Book Hilfe).

E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nur bedingt: Kindle)

Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Mit Wasserzeichen-DRM wird hier ein "weicher" Kopierschutz verwendet. Daher ist technisch zwar alles möglich - sogar eine unzulässige Weitergabe. Aber an sichtbaren und unsichtbaren Stellen wird der Käufer des E-Books als Wasserzeichen hinterlegt, sodass im Falle eines Missbrauchs die Spur zurückverfolgt werden kann.

Weitere Informationen finden Sie in unserer E-Book Hilfe.


Download (sofort verfügbar)

128,39 €
inkl. 5% MwSt.
Download / Einzel-Lizenz
PDF mit Adobe-DRM
siehe Systemvoraussetzungen
E-Book bestellen

128,39 €
inkl. 5% MwSt.
Download / Einzel-Lizenz
PDF mit Wasserzeichen-DRM
siehe Systemvoraussetzungen
E-Book bestellen